Login / Signup

The Role of CYP2D6 Polymorphisms in Determining Response to Tamoxifen in Metastatic Breast Cancer Patients: Review and Egyptian Experience.

Ibrahim MalashOsman MansourSabry ShaarawyMona S AbdellateifAnan OmarRabab GaaferAbdel-Rhaman N ZekriOla S AhmedAbeer Bahnassy
Published in: Asian Pacific journal of cancer prevention : APJCP (2020)
CYP2D6 polymorphisms can significantly predict response to Tamoxifen treatment, and also associates with poor overall survival rates in MBC patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • metastatic breast cancer
  • patient reported outcomes
  • estrogen receptor
  • breast cancer cells
  • patient reported